For research & educational purposes only. This article is a neutral, procedural reference for laboratory / in-vitro research handling — not medical advice or a usage recommendation. These materials are not for human or animal consumption.
What TB-500 is
TB-500 is a lab-made piece of a natural protein your body already uses, called thymosin beta-4. It is supplied as an analytical-grade reference material for laboratory research.
What it does — in plain terms
Your body keeps thymosin beta-4 on hand for building and repair jobs — it helps move repair cells to where they're needed and encourages new blood vessels to form. TB-500 is the active fragment of that protein. So research looks at it for wound healing and recovery: basically helping the body's 'construction crew' cells reach an injury and start rebuilding. It's frequently studied alongside BPC-157 for that reason.
Here's where TB-500 actually shows up in the published research:
- Wound healing
- Cell migration (getting repair cells to an injury)
- New blood-vessel growth
- Muscle and tissue recovery
Plain-language explanations describe what researchers study — not what any product does for a person, and not medical advice. Every material here is sold for laboratory research use only and is not for human or animal use.
Reconstitution reference
Standard laboratory reconstitution volumes for TB-500, from the VNG Reconstitution Sheet. See the full reconstitution guide for the method and concentration math.
| Product | Vial | Bacteriostatic water | Resulting concentration |
|---|---|---|---|
| TB-500 | 10 mg | 2 mL | 5 mg/mL |
| GLOW (GHK-Cu + BPC-157 + TB-500) | 70 mg | 3 mL | ~23.3 mg/mL |
| KLOW (BPC-157 + GHK-Cu + TB-500 + KPV) | 80 mg | 3 mL | ~26.7 mg/mL |
Published research
A selection of peer-reviewed and clinical literature indexed on PubMed. Provided so qualified researchers can locate the primary sources — inclusion here is not a claim about any product or outcome.
- Peer-reviewed studyAnnals of the New York Academy of Sciences · 2007
Beta-thymosins — overview
View on PubMed - Peer-reviewed studyInternational immunopharmacology · 2023
Thymosin beta-4 in regenerative therapy research
View on PubMed - Peer-reviewed studyExpert opinion on biological therapy · 2018
Thymosin beta-4 and the eye
View on PubMed - Peer-reviewed studyCurrent medicinal chemistry · 2020
Thymosin beta-4 and tissue repair in heart injury
View on PubMed - Lab / formulation studyVitamins and hormones · 2016
Thymosin beta-4 and liver (hepatic stellate) cells
View on PubMed - Peer-reviewed studyAnnals of the New York Academy of Sciences · 2010
Thymosin beta-4 tissue-repair peptide — animal studies
View on PubMed - Animal-model studyInternational immunopharmacology · 2023
Thymosin beta-4 and bacterial keratitis
View on PubMed - Animal-model studyKidney international · 2016
Thymosin beta-4 and kidney (glomerular) disease
View on PubMed - Peer-reviewed studyBrain : a journal of neurology · 2014
Thymosin beta-4 in glioblastoma research
View on PubMed - Animal-model studyInternational immunopharmacology · 2023
Thymosin beta-4 and middle-ear healing
View on PubMed
References & resources
Related reference materials
VNG Research Team
VNG Labs supplies analytical-grade reference materials with lot-matched Certificates of Analysis. Our write-ups are neutral, source-cited references for qualified and independent researchers.
More from LearnResearch use only. Not for human consumption or veterinary use. Sold exclusively to qualified researchers for in vitro and laboratory research. These statements have not been evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease. Refrigerate upon receipt. Keep in dark environment.
